FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

30932711000001108: Kanuma 20mg/10ml concentrate for solution for infusion vials (Alexion Pharma UK Ltd) 1 vial (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 11-Nov 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
95567001000001113 Kanuma 20mg/10ml concentrate for solution for infusion vials (Alexion Pharma UK Ltd) 1 vial (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
95567101000001114 Kanuma 20mg/10ml concentrate for solution for infusion vials (Alexion Pharma UK Ltd) 1 vial en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Kanuma 20mg/10ml concentrate for solution for infusion vials (Alexion Pharma UK Ltd) 1 vial Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Kanuma 20mg/10ml concentrate for solution for infusion vials (Alexion Pharma UK Ltd) 1 vial Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Kanuma 20mg/10ml concentrate for solution for infusion vials (Alexion Pharma UK Ltd) 1 vial Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Kanuma 20mg/10ml concentrate for solution for infusion vials (Alexion Pharma UK Ltd) 1 vial Is a Sebelipase alfa 20mg/10ml solution for infusion vials 1 vial true Inferred relationship Existential restriction modifier
Kanuma 20mg/10ml concentrate for solution for infusion vials (Alexion Pharma UK Ltd) 1 vial Has AMP Kanuma 20mg/10ml concentrate for solution for infusion vials (Alexion Pharma UK Ltd) true Inferred relationship Existential restriction modifier
Kanuma 20mg/10ml concentrate for solution for infusion vials (Alexion Pharma UK Ltd) 1 vial Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Kanuma 20mg/10ml concentrate for solution for infusion vials (Alexion Pharma UK Ltd) 1 vial VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Kanuma 20mg/10ml concentrate for solution for infusion vials (Alexion Pharma UK Ltd) 1 vial VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Kanuma 20mg/10ml concentrate for solution for infusion vials (Alexion Pharma UK Ltd) 1 vial Has specific active ingredient Sebelipase alfa false Inferred relationship Existential restriction modifier
Kanuma 20mg/10ml concentrate for solution for infusion vials (Alexion Pharma UK Ltd) 1 vial Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Kanuma 20mg/10ml concentrate for solution for infusion vials (Alexion Pharma UK Ltd) 1 vial Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Kanuma 20mg/10ml concentrate for solution for infusion vials (Alexion Pharma UK Ltd) 1 vial Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Kanuma 20mg/10ml concentrate for solution for infusion vials (Alexion Pharma UK Ltd) 1 vial Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Kanuma 20mg/10ml concentrate for solution for infusion vials (Alexion Pharma UK Ltd) 1 vial Has specific active ingredient Sebelipase alfa true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start